# US 2006/0052335 A1 · Chondroitin synthetase and dna encoding the enzyme

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0052335 A1
- Document ID: US20060052335A1
- Status: Published application
- Kind: A1
- Application number: 10/516,099
- Filed: 2003-05-30
- Published: 2006-03-09
- Earliest claimed: 2002-05-31
- Assignees: Seikagaku Kogyo Kabushiki Kaisha; National Institute of Advanced Industrial Science and Technology
- Inventors: Hisashi Narimatsu; Koji Kimata; Toshikazu Yada; Takashi Sato; Masanori Goto
- Web page: https://patentgrep.com/patent/US20060052335A1

## CPC

- C12N 9/1048: {Glycosyltransferases (2.4)}
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C12P 19/26: Preparation of nitrogen-containing carbohydrates
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

A human-derived novel chondroitin synthase, which is an enzyme for synthesizing a fundamental backbone of chondroitin and has both glucuronic acid transferase activity and N-acetylgalactosamine transferase activity.

## Claims

### Claim 1

A chondroitin synthase which consists of a polypeptide consisting of the amino acid sequence represented by SEQ ID NO:2 or an amino acid sequence consisting of amino acid numbers 97 to 755 in the amino acid sequence represented by SEQ ID NO:2, or a sugar chain-bound polypeptide in which a sugar chain is bound to the polypeptide.

### Claim 2

A chondroitin synthase comprising a polypeptide which has enzyme activity of transferring an N-acetyl-D-galactosamine residue to an N-acetyl-D-galactosamine acceptor or enzyme activity of transferring, a D-glucuronic acid residue to a D-glucuronic acid acceptor, and consists of an amino acid sequence having substitution, deletion, insertion, addition and/or transposition of 1 to 131 amino acid residues in an amino acid sequence consisting of amino acid numbers 97 to 755 in the amino acid sequence represented by SEQ ID NO:2.

### Claim 3 (depends on 2)

The chondroitin synthase according to claim 2, which has enzyme activity of transferring an N-acetyl-D-galactosamine residue from an N-acetyl-D-galactosamine donor to a D-glucuronic acid residue of chondroitin having the D-glucuronic acid residue at the non-reducing end, and has enzyme activity of transferring a D-glucuronic acid residue from a D-glucuronic acid donor to an N-acetyl-D-galactosamine residue of chondroitin having the N-acetyl-D-galactosamine residue at the non-reducing end.

### Claim 4 (depends on 1, 2, 3)

A nucleic acid encoding the chondroitin synthase according to any one of claims 1 to 3.

### Claim 5 (depends on 4)

An expression vector which comprises the nucleic acid according to claim 4.

### Claim 6 (depends on 5)

The expression vector according to claim 5, which is capable of being expressed in a eucaryotic cell.

### Claim 7 (depends on 5, 6)

A transformant which comprises the expression vector according to claim 5 or 6.

### Claim 8 (depends on 7)

A process for producing a chondroitin synthase, which comprises growing the transformant according to claim 7 to produce and accumulate a chondroitin synthase as a grown material, and recovering the chondroitin synthase from the grown material.

### Claim 9 (depends on 1, 2, 3)

A method for synthesizing a sugar chain having a structure represented by the following formula (2), which comprises allowing the chondroitin synthase according to any one of claims 1 to 3 to act on an N-acetyl-D-galactosamine acceptor having a structure represented by the following formula (1) and an N-acetyl-D-galactosamine donor to thereby transfer an N-acetyl-D-galactosamine residue to the N-acetyl-D-galactosamine acceptor.
(GlcUA-GalNAc)n-(GlcUA)m (1)
GalNAc-(GlcUA-GalNAc)n-(GlcUA)m (2)
wherein, in formulae (1) and (2), GalNAc represents the N-acetyl-galactosamine residue; GlcUA represents a D-glucuronic acid residue; n is an integer of 1 or more; m is 1 or 0; and - represents a glycoside bond.

### Claim 10 (depends on 1, 2, 3)

A method for synthesizing a sugar chain having a structure represented by the following formula (4), which comprises allowing the chondroitin synthase according to any one of claims 1 to 3 to act upon a D-glucuronic acid acceptor having a structure represented by the following formula (3) and a D-glucuronic acid donor to thereby transfer a D-glucuronic acid residue to the D-glucuronic acid acceptor:
(GalNAc-GlcUA)n-(GalNAc)m (3)
GlcUA-(GalNAc-GlcUA)n-(GalNAc)m (4)
wherein, in formulae (3) and (4), GalNAc represents an N-acetyl-D-galactosamine residue; GlcUA represents the D-glucuronic acid residue; n is an integer of 1 or more; m is 1 or 0; and - represents a glycoside bond.

### Claim 11 (depends on 1, 2, 3)

Use of the chondroitin synthase according to any one of claims 1 to 3 for synthesis of a sugar chain having a structure represented by the following formula (2) by transferring an N-acetyl-D-galactosamine residue to a D-glucuronic acid residue which is present at the non-reducing end of an N-acetyl-galactosamine acceptor having a structure represented by the following formula (1):
(GlcUA-GalNAc)n-(GlcUA)m (1)
GalNAc-(GlcUA-GalNAc)n-(GlcUA)m (2)
wherein, in formulae (1) and (2), GalNAc represents the N-acetyl-D-galactosamine residue; GlcUA represents a D-glucuronic acid residue; n is an integer of 1 or more; m is 1 or 0; and - represents a glycoside bond.

### Claim 12 (depends on 1, 2, 3)

Use of the chondroitin synthase according to any one of claims 1 to 3 for synthesis of a sugar chain having a structure represented by the following formula (4) by transferring a D-glucuronic acid residue to an N-acetyl-D-galactosamine residue which is present at the non-reducing end of a D-glucuronic acid acceptor having a structure represented by the following formula (3):
(GalNAc-GlcUA)n-(GalNAc)m (3)
GlcUA-(GalNAc-GlcUA)n-(GalNAc)m (4)
wherein, in formulae (3) and (4), GalNAc represents an N-acetyl-D-galactosamine residue; GlcUA represents the D-glucuronic acid residue; n is an integer of 1 or more; m is 1 or 0; and - represents a glycoside bond.

### Claim 13 (depends on 1, 2, 3)

An activity-controlling agent of the chondroitin synthase according to any one of claims 1 to 3.

### Claim 14 (depends on 1, 2, 3, 13)

An agent for treating diseases caused by a change in activity of the chondroitin synthase according to any one of claims 1 to 3, which comprises the activity-controlling agent according to claim 13 as an active ingredient.
